<?xml version="1.0" encoding="UTF-8"?><!-- Generated by Broadridge Transform (tm) - http://www.broadridge.com --><!-- Created: Fri Sep 04 16:00:52 UTC 2026 --><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:common="http://www.sec.gov/edgar/common">
  <schemaVersion>X0202</schemaVersion>
<headerData>
    <submissionType>SCHEDULE 13G/A</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0002152069</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>1</amendmentNo>
      <securitiesClassTitle>Common Shares</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>06/30/2026</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0002066836</issuerCik>
        <issuerName>Conexeu Sciences Inc.</issuerName>
        <issuerCusips>
          <issuerCusipNumber>20715F100</issuerCusipNumber>
        </issuerCusips>
        <issuerPrincipalExecutiveOfficeAddress>
          <common:street1>9921 Georgetown Pike, Suite D203</common:street1>
          <common:city>Great Falls</common:city>
          <common:stateOrCountry>VA</common:stateOrCountry>
          <common:zipCode>22066</common:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(c)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Multi-Valor AIF Umbrella Fund SICAV Quintus Growth Fund</reportingPersonName>
      <citizenshipOrOrganization>N2</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>4314336</soleVotingPower>
        <sharedVotingPower>0</sharedVotingPower>
        <soleDispositivePower>4314336</soleDispositivePower>
        <sharedDispositivePower>0</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>4314336</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <classPercent>9.99</classPercent>
      <typeOfReportingPerson>OO</typeOfReportingPerson>
      <comments>Includes 2,200,000 common shares warrants which may not be exercised by the Reporting Person if such exercise would result in the Reporting Person holding over 9.99% of the Issuer's outstanding common shares on the date of exercise.</comments>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>Conexeu Sciences Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>50 West Liberty Street, Sutie 880, Reno, NV 89501</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>Multi-Valor AIF Umbrella Fund SICAV Quintus Growth Fund ("Reporting Person")</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>c/o VP Fund Solutions (Liechtenstein) AG
Aeulestrasse 6
Vaduz 9490
Principal of Liechtenstein</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Liechtenstein</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>4,314,336

Includes 2,200,000 common shares warrants which may not be exercised by the Reporting Person if such exercise would result in the Reporting Person holding over 9.99% of the Issuer's outstanding common shares on the date of exercise.</amountBeneficiallyOwned>
        <classPercent>Up to 9.99%</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>4,314,336</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>0</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>4,314,336</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>0</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Multi-Valor AIF Umbrella Fund SICAV Quintus Growth Fund</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Robert Sven Soroer</signature>
        <title>Director</title>
        <date>09/04/2026</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
